Comment on: "Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors": reply

Rheumatology (Oxford). 2024 Nov 27:keae646. doi: 10.1093/rheumatology/keae646. Online ahead of print.
No abstract available